Richard A. Larson to Bridged Bicyclo Compounds, Heterocyclic
This is a "connection" page, showing publications Richard A. Larson has written about Bridged Bicyclo Compounds, Heterocyclic.
Connection Strength
0.404
-
Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapy. Leuk Lymphoma. 2024 Jun; 65(6):864-867.
Score: 0.223
-
Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication. Blood Cancer J. 2021 02 18; 11(2):39.
Score: 0.181